{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:47:01Z","timestamp":1768592821753,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bbi.2020.08.024","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:45:38Z","timestamp":1598442338000},"page":"248-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Differential effect of interferon-alpha treatment on AEA and 2-AG levels"],"prefix":"10.1016","volume":"90","author":[{"given":"Zuzanna","family":"Zajkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naghmeh","family":"Nikkheslat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella F.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Tomassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilay","family":"Hepgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Forton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hotopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Zunszain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine M.","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.08.024_b0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.archoralbio.2017.12.005","article-title":"Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts","volume":"87","author":"Abidi","year":"2018","journal-title":"Arch. Oral Biol."},{"issue":"4","key":"10.1016\/j.bbi.2020.08.024_b0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000092678","article-title":"Cannabis-induced psychosis-like experiences are associated with high schizotypy","volume":"39","author":"Barkus","year":"2006","journal-title":"Psychopathology"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2020.08.024_b0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0009-3084(00)00195-X","article-title":"Cannabinoid receptors and the regulation of immune response","volume":"108","author":"Berdyshev","year":"2000","journal-title":"Chem. Phys. Lipids"},{"issue":"6","key":"10.1016\/j.bbi.2020.08.024_b0020","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbi.2020.08.024_b0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.bbi.2020.08.024_b0030","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00213-015-4105-9","article-title":"Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?","volume":"233","author":"Boorman","year":"2016","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2020.08.024_b0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide Suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB 2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bbi.2020.08.024_b0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jcb.1103","article-title":"Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids","volume":"81","author":"Chang","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.bbi.2020.08.024_b0045","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.1500546","article-title":"Anandamide suppresses proinflammatory T cell responses in vitro through type-1 cannabinoid receptor-mediated mTOR inhibition in human keratinocytes","volume":"197","author":"Chiurchi\u00f9","year":"2016","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2020.08.024_b0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbi.2011.01.020","article-title":"The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70\/IL-23 axis and IL-10 in microglial cells","volume":"25","author":"Correa","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.08.024_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.06.007","article-title":"The endocannabinoid system modulates stress, emotionality, and inflammation","volume":"42","author":"Crowe","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.08.024_b0060","doi-asserted-by":"crossref","unstructured":"Croxford, J. L., & Miller, S. D. (2003). Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R (+) WIN55, 212. 111(8), 1231\u20131240. https:\/\/doi.org\/10.1172\/JCI200317652.Introduction.","DOI":"10.1172\/JCI17652"},{"issue":"5090","key":"10.1016\/j.bbi.2020.08.024_b0065","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbi.2020.08.024_b0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbi.2016.07.152","article-title":"Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling","volume":"58","author":"Doenni","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.bbi.2020.08.024_b0075","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2020.08.024_b0080","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s11064-018-2591-y","article-title":"Effects of rTMS on hippocampal endocannabinoids and depressive-like behaviors in adolescent rats","volume":"43","author":"Fang","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2020.08.024_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01027","article-title":"Cannabinoid receptor 2 agonist JWH-015 inhibits interleukin-1\u03b2induced inflammation in rheumatoid arthritis synovial fibroblasts and in adjuvant induced arthritis rat via glucocorticoid receptor","volume":"10","author":"Fechtner","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2020.08.024_b0090","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbi.2019.09.006","article-title":"Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-\u03b1 mouse model of depression","volume":"82","author":"Fitzgibbon","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.08.024_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2018.06.030","article-title":"FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats","volume":"353","author":"Flannery","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.bbi.2020.08.024_b0100","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbi.2020.08.024_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biocel.2014.03.028","article-title":"2-Arachidonoylglycerol modulates human endothelial cell\/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors","volume":"51","author":"Gasperi","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbi.2020.08.024_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-018-0241-4","article-title":"Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia","volume":"8","author":"Haroon","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2020.08.024_b0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","article-title":"Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder","volume":"95","author":"Haroon","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"5\u20136","key":"10.1016\/j.bbi.2020.08.024_b0120","first-page":"681","article-title":"Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression","volume":"23","author":"Hauer","year":"2012","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2020.08.024_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells","volume":"74","author":"Hegde","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbi.2020.08.024_b0130","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/npp.2016.50","article-title":"Transcriptomics in interferon-\u03b1-treated patients identifies inflammation-, neuroplasticity- and oxidative stress-related signatures as predictors and correlates of depression","volume":"41","author":"Hepgul","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.bbi.2020.08.024_b0135","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.bbi.2020.08.024_b0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbi.2020.08.024_b0145","doi-asserted-by":"crossref","unstructured":"Hillard, C. J. (2017). Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? Neuropsychopharmacology\u00a0: Official Publication of the American College of Neuropsychopharmacology. https:\/\/doi.org\/10.1038\/npp.2017.130.","DOI":"10.1038\/npp.2017.130"},{"key":"10.1016\/j.bbi.2020.08.024_b0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbi.2018.06.016","article-title":"Replication and reproducibility issues in the relationship between C-reactive protein and depression: a systematic review and focused meta-analysis","volume":"73","author":"Horn","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2020.08.024_b0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"issue":"8","key":"10.1016\/j.bbi.2020.08.024_b0160","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"45","key":"10.1016\/j.bbi.2020.08.024_b0165","doi-asserted-by":"crossref","first-page":"45034","DOI":"10.1074\/jbc.M306062200","article-title":"Lipopolysaccharide induces anandamide synthesis in macrophages via CD14\/MAPK\/phosphoinositide 3-kinase\/NF-kappaB independently of platelet-activating factor","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2020.08.024_b0170","first-page":"119","article-title":"Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon- \u03b2 : a longitudinal study in multiple sclerosis patients","volume":"179","author":"L\u00f3pez","year":"2014","journal-title":"J. Transl. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2020.08.024_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/abbi.2001.2500","article-title":"Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes","volume":"393","author":"Maccarrone","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbi.2020.08.024_b0180","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.bbi.2020.08.024_b0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00127-002-0557-4","article-title":"Social environment, ethnicity and schizophrenia","volume":"37","author":"Mallett","year":"2002","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"6284","key":"10.1016\/j.bbi.2020.08.024_b0190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbi.2020.08.024_b0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"6441","key":"10.1016\/j.bbi.2020.08.024_b0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbi.2020.08.024_b0205","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbi.2020.08.024_b0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2009.03.019","article-title":"Endocannabinoids and immune regulation","volume":"60","author":"Pandey","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bbi.2020.08.024_b0215","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.3390\/ijms16047057","article-title":"Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation","volume":"16","author":"Patsenker","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2020.08.024_b0220","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fpsyt.2019.00423","article-title":"Glucocorticoid resistance: is it a requisite for increased cytokine production in depression? A systematic review and meta-analysis","volume":"10","author":"Perrin","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2020.08.024_b0225","doi-asserted-by":"crossref","unstructured":"Poleszak, E., Wo\u015bko, S., S\u0142awi\u0144ska, K., Szopa, A., Wr\u00f3bel, A., & Serefko, A. (2018). Cannabinoids in depressive disorders. In Life Sciences (Vol. 213, pp. 18\u201324). Elsevier Inc. https:\/\/doi.org\/10.1016\/j.lfs.2018.09.058.","DOI":"10.1016\/j.lfs.2018.09.058"},{"issue":"1","key":"10.1016\/j.bbi.2020.08.024_b0230","first-page":"31","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2020.08.024_b0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2019.02.026","article-title":"Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants","volume":"149","author":"Romero-Sanchiz","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2020.08.024_b0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.psyneuen.2018.11.032","article-title":"Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome","volume":"100","author":"Russell","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbi.2020.08.024_b0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-5728(94)90152-X","article-title":"Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis","volume":"55","author":"Schwarz","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2020.08.024_b0250","unstructured":"Sheehan, D. V, Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59 Suppl 2, 22-33;quiz 34-57. http:\/\/www.researchgate.net\/publication\/13406551_The_Mini-International_Neuropsychiatric_Interview_(M.I.N.I.)_the_development_and_validation_of_a_structured_diagnostic_psychiatric_interview_for_DSM-IV_and_ICD-10."},{"issue":"9740","key":"10.1016\/j.bbi.2020.08.024_b0255","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(10)60935-X","article-title":"Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial","volume":"376","author":"Topol","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.08.024_b0260","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2016.01.004","article-title":"Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors","volume":"67","author":"Yi","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120302555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120302555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:05:54Z","timestamp":1760169954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120302555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":52,"alternative-id":["S0889159120302555"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.08.024","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effect of interferon-alpha treatment on AEA and 2-AG levels","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}